Michael Højby Rasmussen

20PUBLICATIONS
37CO-AUTHORS
Infant and child healthObstetrics and gynaecologyPharmacogenomicsPharmaceutical delivery technologiesClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 29, 2026
Somapacitan Treatment in Children and Adolescents Born SGA: Two-Year Efficacy and Preference Over Daily GH.

|Aug 01, 2026
Once-weekly somapacitan enhances linear growth in girls with Turner syndrome: a randomized controlled phase 3 study.

|Jun 29, 2026
Model-based somapacitan dosing and IGF-I response in children born SGA or with ISS, Noonan or Turner syndromes.

|Mar 05, 2026
Somapacitan in children born small for gestational age: a randomized controlled phase 3 trial.

Agnès Linglart, Volker Böttcher, Michael Højby

|Mar 03, 2026
Once-weekly somapacitan in children with Noonan syndrome: randomized controlled phase 3 trial.

Alexander A L Jorge, Assunta Albanese, Michael Højby

|Feb 19, 2026
Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study.

Jennifer Abuzzahab, Andrew Dauber, Michael Højby

Pageof 4

Frequent Collaborators

8 joint publications

Jun Mori

5 joint publications

Agnès Linglart

4 joint publications

Rasmus Juul Kildemoes

4 joint publications

Bradley S Miller